@conference{d8f4164ad52b4b7eb2b7616e8252c1cd,
title = "PrognosisAI: A Web-Based Tool for Predicting Six-Month DAS28-Remission in Patients with Rheumatoid Arthritis Initiating Adalimumab as First-Line Biologic Therapy",
author = "Nikolin Prenga and M Kaalep and A Akkoc and T. Kragstrup and Bente Glintborg and Krogh, {Niels Steen}",
note = "COPECARE; Scandinavian Congress of Rheumatology SCR2023 ; Conference date: 23-08-2023 Through 26-08-2023",
year = "2023",
language = "English",
pages = "SCR 52(Supplement 131) (pp 63--65)",
}